Meeting Details
- Board Meeting Date: Saturday, 30 May 2026
Agenda Items
1. Approval of Audited Financial Results (Standalone and Consolidated) for the half year and financial year ended 31 March 2026
2. Consideration and recommendation of Final Dividend, if any, on equity shares for financial year 2025-26
3. Consideration of fundraising through issue of Equity Shares, Warrants or other Securities (convertible or non-convertible) via preferential/rights or other permissible modes, subject to applicable laws and approvals including shareholder, government, regulatory, and statutory approvals
4. Consideration of amendment to Articles of Association of the Company, if applicable
5. Any other matter with permission of the Chair
Additional Considerations
The Board may conduct an Extra-Ordinary General Meeting or Postal Ballot process to seek shareholder approval for the aforementioned proposals.
Trading Window Status
As previously communicated via letter dated 24 March 2026, the trading window for designated persons and their immediate relatives has been closed since 1 April 2026 in compliance with SEBI (Prohibition of Insider Trading) Regulations. The trading window will reopen after 48 hours of the declaration of Audited Financial Results (Standalone and Consolidated).